AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
BeOne Medicines AG
Video analysis: ONC
All videosNo video analysis for this stock yet. Request one from our team.
News: ONC
BeOne Medicines (NASDAQ:ONC) Insider Sells $13,365,991.70 in Stock
BeOne Medicines Ltd. - Sponsored ADR (NASDAQ: ONC - Get Free Report) insider Xiaodong Wang sold 38,287 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $349.10, for a total value of $13,365,991.70. Following the completion of the sale, the insider directly owned 6,079 shares
Oncolytics Biotech (TSE:ONC) Shares Pass Above Two Hundred Day Moving Average – Here’s Why
Oncolytics Biotech Inc. (TSE: ONC - Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of C$14.90 and traded as high as C$14.90. Oncolytics Biotech shares last traded at C$14.90, with a volume of 280 shares. Oncolytics Biotech Price Performance The company has
Nykredit A S Invests $1.20 Million in BeOne Medicines Ltd. – Sponsored ADR $ONC
Nykredit A S purchased a new stake in BeOne Medicines Ltd. - Sponsored ADR (NASDAQ: ONC) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 4,225 shares of the company's stock, valued at approximately $1,204,000. A number of other hedge funds and other
Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers
Trump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.
BeOne Medicines to Present at the Morgan Stanley Annual Global Healthcare Conference
SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Morgan Stanley Annual Global Healthcare Conference on September 14, 2026, with a fireside chat at 11:30 a.m. EDT. The live webcast of this event can be accessed from the investors section of the Company's website at https://ir.beonemedicines.com. An archived webcast will be available on the Company's website. About BeOne Medicin.
BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines
SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale. The agreement builds on BeOne's longstanding commitment to patient access and investment in research and scien.
BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer
SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the second interim analysis (IA2) of the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), in combination with chemotherapy, with and without TEVIMBRA® (tislelizumab), as first-line treatment for HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). At IA2, ZIIHERA plus chemotherapy demonst.
BeOne Medicines Ltd. - Sponsored ADR (ONC) is a Great Momentum Stock: Should You Buy?
Does BeOne Medicines Ltd. - Sponsored ADR (ONC) have what it takes to be a top stock pick for momentum investors?
Similar companies
-
Humana Inc.
HUM
·
New York Stock Exchange
Compare
-
Insmed Incorporated
INSM
·
NASDAQ
Compare
-
GE HealthCare Technologies Inc.
GEHC
·
NASDAQ
Compare
-
ResMed Inc.
RMD
·
New York Stock Exchange
Compare
-
IQVIA Holdings Inc.
IQV
·
New York Stock Exchange
Compare
-
Alcon Inc.
ALC
·
New York Stock Exchange
Compare